Re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020;77:636-43.
This work was supported by the Pillar Program from the Science and Technology Department of Sichuan Province (2018SZ0168 to Yin Tang).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2020]版：
大类|1 区医学
小类|1 区泌尿学与肾脏学
最新[2023]版：
大类|1 区医学
小类|1 区泌尿学与肾脏学
第一作者：
第一作者机构：[1]Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China
通讯作者：
通讯机构：[1]Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China[*1]Department of Urology/Institute of Urology, West China Hospital, Sichuan University, Guoxue Xiang #37, Chengdu, Sichuan 610041, China.
推荐引用方式(GB/T 7714)：
Yunjin Bai,Yubo Yang,Yin Tang.Re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020;77:636-43.[J].European urology.2020,77(6):e158.doi:10.1016/j.eururo.2020.03.008.
APA：
Yunjin Bai,Yubo Yang&Yin Tang.(2020).Re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020;77:636-43..European urology,77,(6)
MLA：
Yunjin Bai,et al."Re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020;77:636-43.".European urology 77..6(2020):e158
医学